Labcorp Holdings (LH) FY2013 results: revenue $5.8 billion, up 2.4% on the year
Labcorp Holdings Inc. (LH) reported revenue of $5.8 billion for fiscal 2013, the year ended 31 December 2013, up 2.4% on the year before. Net income was $574 million, down 1.6%, and diluted earnings per share $6.25. The figures are the company's own, from the 10-K it filed with the SEC on 29 February 2016.
Revenue
$5.8 billion
+2.4% on the year
FY2007FY2013
Operating margin
17.1%
18.0% a year earlier
FY2007FY2013
Net income
$574 million
-1.6% on the year
FY2007FY2013
Diluted EPS
$6.25
+4.3% on the year
FY2007FY2013
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Revenue
5,808
5,671
5,542
+2.4%
Cost of revenue
3,585
3,422
3,268
+4.8%
Gross profit
2,223
2,250
2,275
-1.2%
Gross margin
38.3%
39.7%
41.0%
Selling, general and administrative
1,129
1,115
1,160
+1.3%
Operating income
991
1,024
948
-3.2%
Operating margin
17.1%
18.0%
17.1%
Interest expense
96.5
94.5
87.5
+2.1%
Income tax
340
359
333
-5.3%
Net income
574
583
520
-1.6%
Net margin
9.9%
10.3%
9.4%
Diluted EPS
$6.25
$5.99
$5.11
+4.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Operating cash flow
819
841
856
-2.7%
Capital expenditure
202
174
146
+16.3%
Free cash flow
616
668
710
-7.7%
Free cash flow margin
10.6%
11.8%
12.8%
Cash from investing
-360
-534
-280
Cash from financing
-518
-0.8
-645
Depreciation and amortisation
230
230
231
+0.1%
Share-based compensation
37.3
40.7
48.9
-8.4%
Buybacks
1,016
516
644
+96.6%
Diluted shares, weighted
92m
97m
102m
-5.7%
Shares outstanding at period end
86m
94m
98m
-8.3%
Balance sheet
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Shareholders' equity
2,491
4,945
2,504
-49.6%
Debt
2,986
2,655
2,221
+12.5%
Other liabilities
1,489
n/a
1,387
Total liabilities and equity
6,966
6,795
6,112
+2.5%
Fixed assets
707
631
578
+12.1%
Goodwill
3,023
2,902
2,682
+4.2%
Intangible assets
1,572
1,668
1,621
-5.7%
Cash and equivalents
404
404
159
0.0%
Receivables
785
718
700
+9.2%
Inventory
136
121
111
+12.8%
Other assets
338
351
261
-3.6%
Total assets
6,966
6,795
6,112
+2.5%
10-K for the year ended 31 December 2013, filed 29 February 2016: the filing.